Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

The research, published recently in the journal Clinical Gastroenterology and Hepatology, found that people with belly fat or ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

A medical director of liver transplants in Colorado says he has noticed a worrying rise in the number of young people in ...

Health risks caused by alcohol have received new scrutiny recently, and federal data show the annual number of drug-related ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The risk of serious liver damage from alcohol is more than twice as high for people with belly fat and diabetes, a new study found.

Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according ...

A growing number of young Americans are drinking their way onto the organ transplant list — particularly women.